Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  MetLife    MET

METLIFE (MET)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

Metlife Inc : MetLife Posts Wider 1Q Loss Than Projected On Larger Investment Losses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/27/2012 | 04:08am CEST

("MetLife Posts Wider 1Q Loss Than Projected On Smaller Tax Benefit," published at 4:59 p.m. EDT, and a correction at 5:38 p.m. misstated the reason for MetLife's wider loss. The correct version follows:)

MetLife Inc. (MET) reported a wider first-quarter loss than it projected last week as the life insurer posted larger net investment losses.

Last Friday, the biggest U.S. insurer reported preliminary results after inadvertently posting some of its financial data on its website ahead of the scheduled release.

The company posted a loss of $144 million, or 16 cents a share, widening from the $64 million it estimated last week and compared with the year-earlier profit of $877 million. It posted net investment losses of $110 million, versus the $30 million projected last week.

Operating earnings, which exclude investment gains and losses, came in at $1.37 a share, as reported last Friday. Operating revenue, which likewise strips out some investment effects, also was unchanged at $16.69 billion, up 6.9%.

The bottom-line result was driven by net derivative losses of $1.98 billion, while the year-earlier period's loss was a mere $315 million. Like its fellow insurers, MetLife uses derivatives to hedge a number of risks, including changes in interest rates and fluctuations in foreign currencies.

MetLife said earlier Thursday it is selling its reverse-mortgage business, its latest move to avoid increased regulatory scrutiny and stay focused on its core operations.

In March, it failed "stress tests" by the Federal Reserve that were aimed at gauging the capital adequacy of 19 of the biggest U.S. financial firms under a severe economic worsening.

MetLife shares closed Thursday at $36.47 and were inactive after hours. The stock is up 17% so far this year.

-By Lauren Pollock, Dow Jones Newswires; 212-416-2356; [email protected]

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on METLIFE
05/25METLIFE : WORLDWIDE BENEFITS BOASTS 4th CONSECUTIVE AWARD WIN AT 2018 EMMAs
PU
05/23METLIFE : Board Okays $1.5 Bln Share Buyback Program
AQ
05/22METLIFE INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/22METLIFE : Announces New $1.5 Billion Share Repurchase Authorization
BU
05/22METLIFE : Investment Management, John Buck Company, Golub & Company Announce Fac..
AQ
05/22METLIFE : Free Technical Reports on MetLife and Three Additional Insurance Equit..
AC
05/21METLIFE INVESTMENT MANAGEMENT : The John Buck Company and Golub & Company Announ..
BU
05/21METLIFE : Foundation Partners with Kiva to Support Entrepreneurs and Build Finan..
BU
05/18METLIFE INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/17METLIFE : Launches Plansmart(R) Financial Wellness
AQ
More news
News from SeekingAlpha
05/22MetLife board approves $1.5B stock buyback program 
05/22Financial sector the winner today 
05/22MetLife Moving Past Some Self-Inflicted Challenges And Toward Unlocking Value 
05/21METLIFE : Profitability Is Set To Improve 
05/19Consider Selling When Your Stock Does This 
Financials ($)
Sales 2018 63 426 M
EBIT 2018 5 951 M
Net income 2018 5 334 M
Debt 2018 -
Yield 2018 3,47%
P/E ratio 2018 9,87
P/E ratio 2019 9,08
Capi. / Sales 2018 0,76x
Capi. / Sales 2019 0,75x
Capitalization 48 458 M
Chart METLIFE
Duration : Period :
MetLife Technical Analysis Chart | MET | US59156R1086 | 4-Traders
Technical analysis trends METLIFE
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 54,5 $
Spread / Average Target 14%
EPS Revisions
Managers
NameTitle
Steven Albert Kandarian Chairman, President & Chief Executive Officer
Timothy J. Ring Chief Operating Officer & Senior Vice President
John McCallion Chief Financial Officer, Treasurer & Executive VP
Martin J. Lippert Executive VP-Global Technology & Operations
Jacki Goldstein Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
METLIFE-5.06%48 458
PRUDENTIAL-0.79%65 201
AXA-9.26%63 436
PRUDENTIAL FINANCIAL-13.01%42 008
MANULIFE FINANCIAL CORP.-4.88%38 089
AFLAC3.24%35 101